Month: March 2012

Mexican Genomma would insist on buying U.S. Prestige

|

MONTERREY (Reuters) – the Mexican pharmaceutical Genomma Lab said on Thursday that will insist on its proposal to buy at the American company Prestige Brands, in an operation that could even be made through a hostile offer. Genomma said that he intends to nominate five independent candidates as members of the Council of Administration of Prestige, then that it rejected his proposal to acquire the company from consumer products. “The sole purpose of Genomma to seek nominations “ is to advance in its inadequate, highly conditional proposal and “ seek to acquire Prestige at the lowest possible price”, said Prestige in a statement. The American, to held a shareholders Assembly Next June 29, said it will evaluate the notification of according to the statutes of the company and the legislation force, to make a recommendation on the subject to their shareholders. Genomma announced in February its intention to buy the actions of Prestige at 16.60 dollars per title, in one operation valued at 834 million dollars, excluding debt. Some analysts consider that the Mexican, possessing a 100 shares of Prestige, could raise the price of its offer, but others argue that even a hostile bid could spear to comply with its international expansion plans. “99 Percent of the shares of Prestige are public and “ Genomma is talking to minority shareholders in search of support, we believe that the...

Read More

Bayer makes non binding offer per unit of Pfizer: medium

|

(Reuters) – the pharmaceutical German Bayer conducted an offer not binding for the business of animal health of your couple Pfizer, even though he is considered more likely a split of that unit, reported a German newspaper in an article that will be published in the Friday Edition. The offer of Bayer is based on incomplete data and is in its early stages, reported the Financial Times Deutschland, citing a letter sent to members of the Supervisory Board by Executive President of Bayer, Marijn Dekkers. Pfizer’s President, Ian Read, said in an interview to Reuters on Monday that was most likely a split of the unit animal health before a sale. Rumors about a possible sale of the unit to according to several analysts would have an approximate value of 15,000-20,000 million dollars, were fed in the last week by reports that Novartis AG had made a offer that was rejected by Pfizer, and Bayer was probing financing options. Bayer, the largest pharmaceutical of Germany, declined statements on Thursday on the...

Read More

Specialists meet in Barcelona to move forward in the personalized treatment of COPD

|

BARCELONA, 15 (EUROPA PRESS) Around 300 specialists in Pulmonology and thoracic surgery have started Thursday in Barcelona VIII Symposium of respiratory diseases, which aims to delve into the personalized treatment of the chronic obstructive pulmonary disease (COPD). A key speech specialists that focus is the differentiation by phenotypes of patients with COPD, that may be a step forward for the election of a more appropriate treatment, reported the Organization of the meeting through a press release. The recent discovery of multiple phenotypes enabled to understand COPD as an inflammatory disease of a general nature, but it leaves way personalized to the quality of life of patients. Customizing the treatment also is vital to reduce cardiovascular disease, which show a higher prevalence among COPD patients. Symposium will also analyse the latest developments in bronchoscopy, tuberculosis and lung...

Read More

An EU Latin American program will draw up a pioneer white paper on drugs

|

Vienna, 15 mar ( EFE).- The programme cooperation between Latin America and the EU policy on drugs (COPOLAD), who leads Spain, will draw up a pioneer “White paper” on Narcotics to serve as a reference to both sides of the Atlantic. The book, which will be developed by experts from both continents, will analyse the effectiveness of policies on drugs with the “scientific evidence” available, today explained to Efe Francisco de Asís Babín, delegate of the National Plan on drugs of Spain. Aims to help State policy-makers to make decisions, added the Spanish officer. “How much good can have, to make decisions, information on what was or was not what worked”, said Babín, to emphasise that pioneer, is a project because there is no “white paper” on drugs more than national sphere. COPOLAD, born in early 2011, with headquarters in Madrid and funded by the European Union, is a structure consisting of Spain, Germany, France, Portugal, Argentina, Brazil, Chile, Colombia, Peru and Uruguay. Also collaborate, Costa Rica, Mexico, Ecuador, Romania and Poland, as well as the European Observatory for drugs and drug addiction (EMCDDA) and the Inter-American Commission for the Control of the abuse of drugs (CICAD), among others. Spain proposed the development of the document to their partners at a meeting during the Commission on Narcotic Drugs of the United Nations in Vienna, but the reception was so...

Read More

The PSOE requests health that leads to the adequacy of the packaging of medicines to the duration of treatments

|

MADRID, 15 (EUROPA PRESS) The Socialist Party has registered a proposition rather than act in Congress by calling on the Ministry of health, social services and equality that completion of the adequacy of the content of the packaging of medications for the duration of the treatments in clinical practice, a move driven by in August by the previous Executive which would save 700 million euros per year. So has confirmed it speaking to Europa Press the health spokesman in the Congress and author of this proposal, José Martínez Olmos, who held the position of Secretary-General of the Ministry when last August raised this measure through the Royal Decree-Law 9, 2011, from August 19. Such a rule ordering the Spanish Agency of medicines and products health (AEMPS), under the Ministry, that, within a year, conduct a review of already approved drugs to adapt their packaging to the duration of treatments in the event that these were not suitable. “On many occasions – recalled Martínez Olmos – is not enough with a box to cover treatment, what they end up with many units in the homes of patients”. In fact, according to data from the collection of drugs SIGRE system, each month are reflected in offices of pharmacy 300 tons of domestic medicines. Martínez Olmos assures that, as are reviewing the packaging and closing the modifications to be done, manufacturers could...

Read More

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips